drugset / Trial / NCT07189377
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
NaSingle-groupOpen-labelPrevention
Summary
The aim of the study is to show that transplantation of lungs from Hepatitis B-infected donors is safe when using EVLP with UV light inactivation plus antivirals
Timeline
- Start
- 2025-09-24
- Primary completion
- 2027-08
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | 1 mg | Oral |
| Subject | hepatitis B immune globulin | Protein / enzyme biologic | 4500 iu | Intravenous |